Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Stryker Corporation, a global leader in medical technologies, will release its third quarter 2026 financial results on October 29, 2026, followed by a webcast to discuss the performance. A press release with summary financial information will be issued shortly before the webcast, providing investors and analysts access to the company's latest finan…
Linkhome Holdings Inc. has launched GPU Marketplace 2.0, a public platform enabling customers to rent GPU computing capacity from individuals and data centers. The marketplace aims to improve access to on-demand AI computing resources and optimize the use of idle GPUs, supporting NVIDIA GPUs like GeForce RTX 5090, H100, and B200. While the platform…
Aptera Motors Corp. announced a reduced capital requirement to start production of its solar electric vehicles, lowering estimates from $40-$45 million to approximately $25 million. The company attributes these savings to a strategic partnership with Launch Design which improves manufacturing efficiencies and supplier access. The first 40 productio…
Clover Health announced its 2027 Medicare Advantage plans featuring $0 to low premium PPO options, broad provider networks with no referrals required, and inclusion of preventive care benefits. Powered by its Clover Assistant platform, the plans focus on improving clinical decision-making and member outcomes. The company's approach targets affordab…
Orchestra BioMed has exceeded its full enrollment goal for the BACKBEAT Global Pivotal Trial testing AVIM Therapy, an innovative treatment integrated with pacemakers for patients with uncontrolled hypertension. The trial involves 330 patients randomized globally, surpassing the target of 316. Results are expected in Q2 2027 and could support regula…
Taysha Gene Therapies announced multiple presentations at the 55th Child Neurology Society Annual Meeting highlighting new safety and efficacy data for its TSHA-102 gene therapy program targeting Rett syndrome. The company will present results from the REVEAL Part A Phase 1/2 clinical trial showing multi-domain functional gains, further supporting …
Minerals Technologies Inc. has initiated a private offering of $400 million in senior notes due 2034, aiming to redeem its outstanding 5.000% senior notes due 2028 and cover related transaction costs. The offering targets qualified institutional buyers and non-U.S. persons under exemptions from registration. There is no guarantee the offering will …
HubSpot (HUBS) is a high-quality CRM/SaaS operator trading at an attractive entry point after a sharp derating in 2026. Solid free cash flow, a reasonable EV/FCF, and secular tailwinds around AI-enabled marketing make a long trade compelling. This idea lays out an actionable entry, stop and target with a 180-trading-day time horizon and a balanced …
nVent Electric plc has completed the acquisition of Maverick Power for $1.75 billion, with additional earn-out potential, expanding its power distribution solutions and offerings tailored for data centers. This strategic move enhances nVent's position in the high-growth infrastructure sector by adding new power architectures and system-level soluti…
XPO, Inc., a leading North American freight transportation company, has opened two new service centers in Mesa, Arizona, and Cameron, Missouri. These new facilities enhance XPO's capacity in the fast-growing Phoenix and Kansas City metropolitan freight markets, supporting increasing demand driven by industrial investment and cross-border trade. The…
Woori Financial (WF) combines a sub-1.0 PB, single-digit P/E and a 3.4% yield with improving technicals and low short interest days-to-cover. This trade plan looks for a recovery toward the 52-week high at $84.71 over a 180 trading-day horizon, while limiting downside risk with a $70 stop.
InflaRx N.V., a biopharmaceutical company specializing in complement system-targeted anti-inflammatory therapeutics, announced the appointment of Dr. Gabriela Alperovich as Senior Vice President and Global Head of Clinical Development. Dr. Alperovich brings over 20 years of clinical development leadership with expertise in immune-inflammatory and r…
Streamex Corp. (NASDAQ: STEX), focused on commodity market tokenization, announced CEO Henry McPhie's October trip to Singapore and Hong Kong for multiple digital asset and investment events. The tour aims to engage institutional investors and partners to expand adoption of Streamex's gold-backed tokenized security, GLDY, and strengthen presence in…
Arbutus Biopharma Corporation announced the final results of its modified Dutch auction tender offer to repurchase up to US$230 million of its common shares. The company accepted 46 million shares at US$5.00 each, representing approximately 23% of its outstanding shares. The offer was oversubscribed, resulting in proration of shares tendered at or …
Wave Life Sciences announced alignment with FDA on a two-year registrational trial plan for WVE-006, an RNA editing therapy targeting alpha-1 antitrypsin deficiency (AATD). The FDA supports a one-year interim analysis for potential accelerated approval based on biomarkers. WVE-006 aims to treat both lung and liver manifestations of AATD with a subc…
FTI Consulting has appointed Christina Morris as a Senior Managing Director in its Healthcare Risk Management & Advisory practice to enhance AI and automation capabilities in healthcare compliance and risk management. Morris brings over 25 years of experience in driving technology-enabled transformations, including AI and hyperautomation, aiming to…
Helus Pharma, previously known as Cybin Inc., has legally changed its name to reflect its transition from a clinical-stage discovery company to a commercial-ready pharmaceutical company focused on developing novel serotonergic agonists (NSAs) for mental health treatment. The company maintains its listing on Nasdaq and Cboe Canada under the ticker H…
Bentley Systems is a core infrastructure software franchise trading at a reasonable premium to growth. Recent government AI programs and accelerating digital-twin adoption make Bentley a practical AI beneficiary rather than a speculative AI play. For disciplined traders, there is a mid-term swing opportunity to $40 with a strict stop under $29.
UiPath's acceleration in large-account adoption (387 million-dollar customers, +21% y/y) and improving profitability (positive free cash flow) create a favorable setup for a mid-term long. Valuation is reasonable at sub-16-19x earnings and ~3.5x EV/Sales, while sentiment and technicals leave room for a re-rating if growth stabilizes. Trade plan inc…
I reversed my prior view on Swire Pacific (SWRBF). The combination of steadier cash flows from beverage and property operations, clearer catalysts for value unlocking, and a cleaner technical base produce an asymmetric trade. Plan: enter at $5.40, stop at $4.50, target $7.20; primary horizon mid term (45 trading days) with a longer-term leash to $7…
Edible Garden AG Incorporated has entered into a contract to purchase a 6.2-acre property in Webster City, Iowa, to establish its Prairie Hills ready-to-drink (RTD) manufacturing platform. This acquisition transitions the company from tenant to owner, providing greater control over the strategic manufacturing asset aimed at expanding its Farm-to-Fo…
Huntington (HBAN) looks inexpensive on headline multiples but faces an environment where persistent rate volatility and softer loan growth could keep net interest income under pressure. Management's aggressive buyback program cushions downside, but it also reduces the stock's upside potential. We lay out a mid-term short trade with clear entry, sto…
Unicycive Therapeutics, a Nasdaq-listed clinical-stage biotech focused on kidney disease treatments, appointed Meredith Manning, an experienced biopharmaceutical executive, to its Board of Directors. Her expertise in commercialization and successful drug launches is expected to support Unicycive’s progression toward potential FDA approval of its le…
Lantronix Inc. announced that its Open-Q 8550CS System-on-Module (SOM) has been added to the U.S. Department of War's Blue UAS Framework, a vetted list of NDAA-compliant components for unmanned aircraft systems. This listing validates the security and supply chain integrity of Lantronix's AI compute module, simplifying procurement for drone OEMs in…
OrthoPediatrics Corp., a company specializing in pediatric orthopedic products, sponsored the 10th Pediatric Orthopedic Surgical Techniques (POST) Course. The event featured expert instruction, hands-on training, and networking for senior residents, fellows, and early-career surgeons. It also introduced a new companion manual to enhance educational…
